Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment

By sjmartinez • March 19, 2023

Llovet JM, Willoughby CE, Singal AG, Greten TF, Heikenwälder M, El-Serag HB, Finn RS, Friedman SL. Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment. Nat Rev Gastroenterol Hepatol. 2023 Mar 17. doi: 10.1038/s41575-023-00754-7. Epub ahead of print. PMID: 36932227.

Tags: Hematology/Oncology, Publications

Preclinical Efficacy of the Antibody-Drug Conjugate CLDN6-23-ADC for the Treatment of CLDN6-Positive Solid Tumors

McDermott MSJ, O'Brien NA, Hoffstrom B, Gong K, Lu M, Zhang J, Luo T, Liang M, Jia W, Hong JJ, Chau K, Davenport S, Xie ...

Early-stage CCNG1+ HR+ HER2+ Invasive Breast Carcinoma in Older Women: Current Treatment and Future Perspectives for DeltaRex-G, a CCNG1Inhibitor

Chawla SP, Olevsky O, Iyengar G, Brigham DA, Omelchenko N, Thomas S, Suryamohan K, Foshag L, Hall FL, Gordon EM. Early-stage CCNG1+ HR+ HER2+ Invasive Breast ...

Year 2. May 30. Educational Excellence.

As we celebrate the accomplishments of our trainees and the students at the David Geffen School of Medicine (DGSOM) this graduation season, I am reminded ...